These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 33557879)
1. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879 [TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer. Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701 [TBL] [Abstract][Full Text] [Related]
3. Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer. Liu H; Gu X; Wang G; Huang Y; Ju S; Huang J; Wang X Aging (Albany NY); 2019 Aug; 11(16):6089-6108. PubMed ID: 31442207 [TBL] [Abstract][Full Text] [Related]
4. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation. Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042 [TBL] [Abstract][Full Text] [Related]
5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer. Wang R; Li Y; Du P; Zhang X; Li X; Cheng G Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759 [TBL] [Abstract][Full Text] [Related]
7. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence. Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881 [TBL] [Abstract][Full Text] [Related]
8. The transcriptome profiles and methylation status revealed the potential cancer-related lncRNAs in patients with cervical cancer. Yuan LY; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Wang XJ; Xing H J Cell Physiol; 2019 Jun; 234(6):9756-9763. PubMed ID: 30362566 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma. Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia. James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353 [TBL] [Abstract][Full Text] [Related]
11. Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer. Luo W; Wang M; Liu J; Cui X; Wang H J Cell Physiol; 2020 Feb; 235(2):993-1000. PubMed ID: 31332778 [TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of multi-omics data reveals a pseudouridine-related lncRNA signature for prediction of glioma prognosis and chemoradiotherapy sensitivity. Yang Y; Wang F; Teng H; Zhang C; Zhang Y; Chen P; Li Q; Kan X; Chen Z; Wang Z; Yu Y Comput Biol Med; 2023 Nov; 166():107428. PubMed ID: 37748218 [TBL] [Abstract][Full Text] [Related]
13. Cervical cancer-specific long non-coding RNA landscape reveals the favorable prognosis predictive performance of an ion-channel-related signature model. Wang B; Wang W; Zhou W; Zhao Y; Liu W Cancer Med; 2024 Jun; 13(11):e7389. PubMed ID: 38864475 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Liu T; Liu Y; Su X; Peng L; Chen J; Xing P; Qiao X; Wang Z; Di J; Zhao M; Jiang B; Qu H Comput Biol Med; 2023 Feb; 153():106545. PubMed ID: 36646024 [TBL] [Abstract][Full Text] [Related]
15. Identification of Three Prognosis-Related Differentially Expressed lncRNAs Driven by Copy Number Variation in Thyroid Cancer. Tian J; Luo B J Immunol Res; 2022; 2022():9203796. PubMed ID: 35642209 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis. Song Y; Yang K; Sun T; Tang R BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178 [TBL] [Abstract][Full Text] [Related]
17. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer. Xu Y; Wu T; Li F; Dong Q; Wang J; Shang D; Xu Y; Zhang C; Dou Y; Hu C; Yang H; Zheng X; Zhang Y; Wang L; Li X Brief Bioinform; 2020 Dec; 21(6):2153-2166. PubMed ID: 31792500 [TBL] [Abstract][Full Text] [Related]
18. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162 [TBL] [Abstract][Full Text] [Related]
19. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer. Tyagi N; Roy S; Vengadesan K; Gupta D Noncoding RNA Res; 2024 Mar; 9(1):66-75. PubMed ID: 38075203 [TBL] [Abstract][Full Text] [Related]
20. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma. Li M; Long S; Hu J; Wang Z; Geng C; Ou S Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]